84 results
8-K
EX-99.1
BRSF
Brain Scientific Inc.
2 Nov 22
Daniel Cloutier, a Veteran Sales Executive, Joins Brain Scientific as Chief Revenue Officer
5:56pm
; lack of product diversification; volatility in the price of the company's raw materials; and the failure to implement the company's business plans
D
md9hvo
19 Jul 22
$5.15M in debt / options, sold $5.15M, 11 investors
12:59pm
DEF 14C
38dzdo8454r fl0b6bzc
5 Jul 22
Information statement
11:02am
PRE 14C
u1t7rcg5p82p1oo4u
24 Jun 22
Preliminary information
12:36pm
8-K
EX-10.1
29e1509148q
15 Jun 22
Entry into a Material Definitive Agreement
11:15am
8-K
EX-99.1
9r1oiadl
15 Jun 22
Entry into a Material Definitive Agreement
11:15am
8-K
EX-99.1
ku5lkq811mq0mm3pmy
19 Apr 22
Regulation FD Disclosure
3:18pm
8-K
7nvx1jrg
19 Apr 22
Regulation FD Disclosure
3:18pm
8-K
EX-10.1
o6gu368qp 2akd
16 Feb 22
Entry into a Material Definitive Agreement
4:01pm
8-K
1euvzf
13 Jan 22
Regulation FD Disclosure
5:28pm
8-K
EX-99.1
jjyx6hrulc ihw8h3469
13 Jan 22
Regulation FD Disclosure
5:28pm
D
x8mecm77pfl
13 Jan 22
$20M in debt / options, sold $9.66M, 13 investors
4:33pm
8-K
EX-10.1
69a1c 39bm3r
28 Dec 21
Entry into a Material Definitive Agreement
4:18pm
8-K/A
EX-99.2
xeybxm mp2aa
15 Dec 21
Audited Consolidated Financial Statements
10:49am